Antibody-drug conjugates: strategies, experiences and challenges from the non-clinical development to clinical development in cancer treatment in France

被引：0
|
作者：
Burbank, M. G. [1 ]
Menoret, C. [1 ,2 ]
Lopes, S. [1 ]
Gazin, V. [1 ]
Boudali, L. [1 ]
机构：
[1] French Natl Agcy Med & Hlth Prod Safety ANSM, Oncol Div, St Denis, Reunion, France
[2] Francois Rabelais Univ, Tours, France
来源：
TOXICOLOGY LETTERS | 2018年 / 295卷
关键词：
D O I：
10.1016/j.toxlet.2018.06.965
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
P19-28
引用
收藏
页码：S228 / S229
页数：2
相关论文
共 50 条
  • [31] Clinical development of antibody-drug conjugates in triple negative breast cancer: can we jump higher?
    Zardavas, Dimitrios
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (06) : 633 - 644
  • [32] PREDICTION OF HUMAN PHARMACOKINETICS (PK) OF ANTIBODY-DRUG CONJUGATES (ADCS) FROM SIMPLE ALLOMETRY OF NON-CLINICAL DATA.
    Yang, J.
    Zhao, B.
    Jang, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S52 - S52
  • [33] DRUG DEVELOPMENT ADC Therapeutics will focus on antibody-drug conjugates for cancer
    Thayer, Ann
    CHEMICAL & ENGINEERING NEWS, 2012, 90 (14) : 7 - 7
  • [34] DESIGN AND CLINICAL DEVELOPMENT OF ANTIBODY DRUG CONJUGATES
    Lutzker, S.
    ANNALS OF ONCOLOGY, 2013, 24 : 15 - 15
  • [35] Recent Advances in the Development of Antibody-Drug Conjugates in Urothelial Cancer
    Alhalabi, Omar
    Altameemi, Lina
    Campbell, Matthew T.
    Meric-Bernstam, Funda
    CANCER JOURNAL, 2022, 28 (06): : 417 - 422
  • [36] The clinical development of antibody–drug conjugates — lessons from leukaemia
    Elias Jabbour
    Shilpa Paul
    Hagop Kantarjian
    Nature Reviews Clinical Oncology, 2021, 18 : 418 - 433
  • [37] Antibody-drug conjugates treatment of small cell lung cancer: advances in clinical research
    Meng, Yuan
    Wang, Xuerui
    Yang, Jie
    Zhu, Meiying
    Yu, Minghui
    Li, Longhui
    Liang, Yangyueying
    Kong, Fanming
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [38] Clinical pharmacology strategies in supporting drug development and approval of antibody–drug conjugates in oncology
    Stephanie N. Liu
    Chunze Li
    Cancer Chemotherapy and Pharmacology, 2021, 87 : 743 - 765
  • [39] Development of next generation antibody-drug conjugates
    Parks, Lisa
    BIOANALYSIS, 2013, 5 (12) : 1472 - 1472
  • [40] Targeting cancer with antibody-drug conjugates: Promises and challenges
    Dean, Alexis
    Twomey, Julianne
    Zhang, Baolin
    CANCER RESEARCH, 2020, 80 (16)
12345